Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence (2019)
Attributed to:
Understanding and manipulating innate-like B cell mechanisms to prevent stroke-associated infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/f1000research.19308.1
Publication URI: http://dx.doi.org/10.12688/f1000research.19308.1
Type: Journal Article/Review
Parent Publication: F1000Research